TABLE-Cyfuse Biomedical -2025 parent results

About this update from Cyfuse Biomedical K.k.

Feb 13 (Reuters)- Cyfuse Biomedical K.K. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Dec 31, 2025 Dec 31, 2024 Dec 31, 2026 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 230 mln 54 mln 278 mln (+324.3 pct) (-10.9 pct) (+20.4 pct) Operating loss 828 mln loss 896 mln loss 1.08 Recurring loss 761 mln loss 869 mln loss 1.06 Net loss 763 mln loss 872 mln loss 1.06 EPS loss 86.78 yen loss 108.34 yen loss 110.22 yen Ann Div NIL NIL NIL -Q2 Div NIL NIL NIL -Q4 Div NIL NIL NIL NOTE - Cyfuse Biomedical K.K.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T

View stock analysis, news, and events for Cyfuse Biomedical K.k.